Monday, December 23, 2024
HomeTagsEnzyme Technology Platform

Enzyme Technology Platform

Hansa Biopharma Announces $70 Million Non-dilutive Product Finance Transaction With Novaquest

Hansa Biopharma AB, a pioneer in enzyme technology for rare immunological conditions, announces that the Company has entered into an agreement with U.S.-based NovaQuest...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics